Supplementary Figure S4 from scFv-Based “Grababody” as a General Strategy to Improve Recruitment of Immune Effector Cells to Antibody-Targeted Tumors

Abstract

<p>Supplementary Figure S4 PDF file 583K, In vivo activity of h4D5 in the T6-17 model</p>